https://doctransparency.com/doctor/fl/orlando/steven-smith-1497988927
Not Medicare Enrolled

Dr. Steven Smith, M.D.

Endocrinology · Orlando, FL
Consulting-driven
301 E. PRINCESTON ST., Orlando, FL 32804
4073037115
In practice since 2009 (16 years)
NPI: 1497988927 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Smith

Dr. Steven Smith is an endocrinology in Orlando, FL, with 16 years in practice.

Between the years covered by Open Payments, Dr. Smith received a total of $425,507 from 15 pharmaceutical and/or device companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Smith is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice$ $425,507 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$425,507
Total received (2018-2024)
Avg $70,918/year across 6 years
Top 3% in FL for endocrinology
15
Companies
156
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$398,401 (93.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,024 (5.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,082 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$321,966
2023
$43,183
2022
$12,418
2021
$7,650
2019
$4,149
2018
$36,141

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Zealand Pharma A/S
$300,663
Novo Nordisk Inc
$49,599
Eli Lilly and Company
$23,267
SANOFI-AVENTIS U.S. LLC
$22,436
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,065
Eisai Inc.
$4,995
Genentech, Inc.
$4,149
Amgen Inc.
$1,046
Regeneron Pharmaceuticals, Inc.
$548
E.R. Squibb & Sons, L.L.C.
$198
Medtronic, Inc.
$175
Boehringer Ingelheim International GmbH
$125
Stryker Corporation
$106
Siemens Medical Solutions USA, Inc.
$86
Corcept Therapeutics
$50
Top 3 companies account for 87.8% of total payments
Associated products mentioned in payments ›
Artis pheno · Korlym · NO PRODUCT DISCUSSED · Non-Covered Product · SIGNIA · Saxenda · VSP CRANIAL · VSP SYSTEM
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for endocrinology in FL.

Looking for a endocrinology in Orlando?
Compare endocrinologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
60
Per 100K population
4.2
County median income
$77,011
Nearest hospital
ASPIRE HEALTH PARTNERS
3.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Smith is a endocrinology, and high industry engagement (consulting-driven, top 3%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $425,507 from 15 companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in Orlando
Browse endocrinologys in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in FL
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in FL
Which FL endocrinologys receive the most from drug and device companies.
By company
Zealand Pharma A/S Payments to Doctors
See all physicians who received payments from Zealand Pharma A/S.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →